Skip to main content
ADCES26 Main banner
Visit TZIELD at Booth #1510 (Sanofi Ad)

Cardiometabolic Conditions and Treatment Options

(D26) When Blood Pressure Won’t Budge: Managing Resistant Hypertension in People with Diabetes

Sunday, August 9, 2026
2:50 PM - 3:35 PM ET
CE: .75 CE
Pharmacology Hours: .50 CE
Hypertension and diabetes frequently coexist and together markedly increase cardiovascular and kidney risk, making blood pressure management a cornerstone of diabetes care. This session prepares DCESs to identify, classify, and manage complex hypertension in people with diabetes using new recommendations from the 2025 American College of Cardiology and American Heart Association’s Hypertension Guideline. Attendees will learn a practical approach to differentiating resistant from secondary hypertension, including appropriate indications for screening for secondary causes. The session will also review recent clinical trial data and guideline updates to support individualized blood pressure targets and evidence-based treatment strategies for optimizing blood pressure management in people with diabetes.

Learning Objectives:

At the completion of this activity, participants should be able to:
  • Describe a practical approach for differentiating resistant hypertension from secondary hypertension using the 2025 ACC/AHA Guidelines.
  • Determine blood pressure goals for people with hypertension and diabetes based on recent clinical trials.
  • Apply evidence-based treatment strategies to optimize blood pressure control in people with diabetes and resistant HTN.
Disclosure(s):
Stacey M. Cutrell, PharmD, BCACP, CDCES: No financial relationships to disclose
John Bucheit, Pharm.D., BCACP, CDCES, FCCP, FADCES: No financial relationships to disclose